Richard Little, MD, is the Head of Hematologic, HIV, and Stem Cell Therapies, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD. Dr Little completed his medical doctorate at the University of South Carolina, Columbia, SC, in 1989. He then completed his residency in internal medicine at the Boston City Hospital, Boston, MA, before going on to complete his oncology/hematology fellowship in 1994 at the National Heart Lung and Blood Institute, Bethesda, MD, and the National Cancer Institute, Rockville, MD.
Speaking on viral lymphomas and cellular therapies
Dr Little’s research interests have focused on viral lymphomas and its therapies, in particular immunotherapy and anti-angiogenesis. His recent involvement included coordinating a Phase II clinical trial of EPOCH chemotherapy in AIDS-related lymphoma.